Biodexa Pharmaceuticals plc ADS/$BDRX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Biodexa Pharmaceuticals plc ADS
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
- Ticker
- $BDRX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 11
- Headquarters
- Cardiff, United Kingdom
- Website
- www.biodexapharma.com
BDRX Metrics
BasicAdvanced
$638K
-
-$12.79
1.18
-
Price and volume
Market cap
$638K
Beta
1.18
52-week high
$5.08
52-week low
$0.57
Average daily volume
7.7M
Financial strength
Current ratio
2.409
Quick ratio
2.409
Interest coverage (TTM)
-58.15%
Profitability
EBITDA (TTM)
-11.716
Effective tax rate (TTM)
-2.41%
Management effectiveness
Return on assets (TTM)
-40.11%
Return on equity (TTM)
-42.00%
Valuation
Price to book
0.05
Price to tangible book (TTM)
0.13
Price to free cash flow (TTM)
-0.027
Free cash flow yield (TTM)
-3,703.70%
Free cash flow per share (TTM)
-22.959
Growth
Earnings per share change (TTM)
-95.05%
BDRX Financial Performance
Revenues and expenses
BDRX Earnings Performance
Company profitability
Upcoming events
No upcoming events
BDRX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.